Clinical Trial Update: Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of biochemotherapy with bevacizumab followed by consolidation therapy with ipilimumab in metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• ipilimumab (ipilimumab)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED